The future of systemic therapy for cutaneous squamous cell carcinoma (CSCC) is rapidly evolving, with research focused on ...
What is the work you’re leading at KaliVir as CEO? Our goal is to develop viral treatments that can reach and eliminate cancer cells in the body, bringing us closer to a cure for all cancer patients.
Dr. Van Morris presents the new evidence-based guideline on systemic therapy for localized anal squamous cell carcinoma. Dr. Morris discusses the key recommendations from the Expert Panel, including ...
The FDA has approved zenocutuzumab-zbco (BIZENGRI) for adults with advanced, unresectable or metastatic NRG1 fusion-positive ...
Trials in Progress: The Power of Timely Cancer Clinical Trial Communication Gastric cancer (GC) and esophageal cancer (EC) are the fifth and seventh leading causes of cancer-related mortality globally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results